Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
MYC regulation of a "poor-prognosis" metastatic cancer cell state
Anita Wolfer, Ben S Wittner, Daniel Irimia, et al.
Molecular Cancer Therapeutics
|
January 25, 2020
Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression
Shweta Joshi, Kevin X Liu, Muamera Zulcic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2020
Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation
Chao Liu, Sayed H Sadat, Koji Ebisumoto, et al.
Scientific Reports
|
May 11, 2023
Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation
Kyle Ford, Brenton P Munson, Samson H Fong, et al.
Research Square
|
November 14, 2023
YAP-Driven Malignant Reprogramming of Epithelial Stem Cells at Single Cell Resolution
J Silvio Gutkind, Farhoud Faraji, Sydney Ramirez, et al.
Brain : a Journal of Neurology
|
June 24, 2008
Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
Philip L De Jager, Elizabeth Rossin, Saumyadipta Pyne, et al.
Cell
|
June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
Claudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Cancer Discovery
|
April 29, 2014
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors
David J Konieczkowski, Cory M Johannessen, Omar Abudayyeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome
Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Science Translational Medicine
|
August 17, 2012
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4
Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2010
MYC regulation of a "poor-prognosis" metastatic cancer cell state
Anita Wolfer, Ben S Wittner, Daniel Irimia, et al.
Molecular Cancer Therapeutics
|
January 25, 2020
Macrophage Syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression
Shweta Joshi, Kevin X Liu, Muamera Zulcic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2020
Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation
Chao Liu, Sayed H Sadat, Koji Ebisumoto, et al.
Scientific Reports
|
May 11, 2023
Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation
Kyle Ford, Brenton P Munson, Samson H Fong, et al.
Research Square
|
November 14, 2023
YAP-Driven Malignant Reprogramming of Epithelial Stem Cells at Single Cell Resolution
J Silvio Gutkind, Farhoud Faraji, Sydney Ramirez, et al.
Brain : a Journal of Neurology
|
June 24, 2008
Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
Philip L De Jager, Elizabeth Rossin, Saumyadipta Pyne, et al.
Cell
|
June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
Claudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Cancer Discovery
|
April 29, 2014
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors
David J Konieczkowski, Cory M Johannessen, Omar Abudayyeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome
Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Science Translational Medicine
|
August 17, 2012
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4
Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.
Page
of 14